NIH committee uncovers gaps in osteoporosis drug therapy evidence - Healio

NIH committee uncovers gaps in osteoporosis drug therapy evidence  Healio

The overall evidence indicates that drug therapies for osteoporosis reduce the risk for clinical fractures, but long-term use may increase the risk for rare, but ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more